Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
Felix Oh,1 Deborah Todhunter,1 Elizabeth Taras,1 Daniel A Vallera,1,2 Antonella Borgatti2,3 1Department of Therapeutic Radiology-Radiation Oncology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; 2Animal Cancer Care and Research (ACCR) Program, University of Minnesota, St. Pau...
Guardado en:
Autores principales: | Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4316ff848881453dbef3dc18798412cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities
por: Virginia Metrangolo, et al.
Publicado: (2021) -
Ultrastructural Characterization of the Pars Distalis of the Indian Female Sheath-Tailed Bat, Taphozous longimanus (Hardwicke)
por: Nerkar,Archana A, et al.
Publicado: (2010) -
Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer
por: Ahmed MSU, et al.
Publicado: (2017) -
Rhabdomyosarcoma of the uterus in an adult patient with osteopetrosis: a case report
por: Soheila Aminimoghaddam, et al.
Publicado: (2021) -
Rhabdomyosarcoma of urethra a rare case presentation
por: N. Thapa, et al.
Publicado: (2016)